From: Functional genomics of AP-2α and AP-2γ in cancers: in silico study
Cohort | Description |
---|---|
BLCA | Bladder urothelial carcinoma |
BRCA | Breast invasive carcinoma |
CESC | Cervical and endocervical cancers |
COAD | Colon adenocarcinoma |
ESCA | Esophageal carcinoma |
GBM | Glioblastoma multiforme |
HNSC | Head and neck squamous cell carcinoma |
KIRC | Kidney renal clear cell carcinoma |
KIRP | Kidney renal papillary cell carcinoma |
LGG | Brain lower grade glioma |
LIHC | Liver hepatocellular carcinoma |
LUAD | Lung adenocarcinoma |
LUSC | Lung squamous cell carcinoma |
OV | Ovarian serous cystadenocarcinoma |
PAAD | Pancreatic adenocarcinoma |
PRAD | Prostate adenocarcinoma |
READ | Rectum adenocarcinoma |
SKCM | Skin cutaneous melanoma |
STAD | Stomach adenocarcinoma |
THCA | Thyroid carcinoma |
UCEC | Uterine corpus endometrial carcinoma |